John Roberts

John Roberts is a highly experienced professional in clinical pharmacology, currently serving as Senior Director Clinical Pharmacology at Biogen since November 2022, where leadership of a team of Clinical Pharmacologists is a primary responsibility. Prior to this role, John held significant positions at CSL Behring, including Senior Director of Clinical Pharmacology and Pharmacometrics, as well as Director of Clinical Pharmacology and Early Development. At Novartis, contributions included being a Fellow in Oncology Clinical Pharmacology and Senior Investigator, leading projects on notable therapies such as CTL019 and Canakinumab. Earlier experience includes a position as Scientist in Discovery Quantitative Pharmacology at AstraZeneca and a role as Junior Scientist at the University of Minnesota. Educational credentials encompass a Ph.D. in Pharmaceutics from the University of Minnesota, a Master of Music in Violin Performance from the same institution, and a Bachelor of Arts in Chemistry from Macalester College.